Erin A. Bohula at LBS 1 briefing

Erin Bohula, M.D., D.Phil., Assistant Professor, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital Investigator, TIMI Study Group, Boston, presents findings in Effect of Evolocumab in the abstract "Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial (LBS 1) at the embargoed media briefing at Scientific Sessions 2025.

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (504.1 kB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED